Tg Therapeutics TGTX
NASDAQ TGTX
$56.56 +0.37 (+0.66%)
As of: Sep 30, 2026 · 1:06 PM EDT

Tg Therapeutics, Inc. (TGTX) Research & Development (2011 - 2026)

Updated

Tg Therapeutics' Research & Development came in at $95.34 million for Q2 2026, up 200.0% from $31.78 million a year earlier and up 97.0% from the prior quarter.

Analysis

Tg Therapeutics, Inc. (TGTX) Research & Development (2011 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Tg Therapeutics reported Research & Development of $225.8 million, up 84.8% year-over-year; for FY2025, it came in at $160.22 million, up 69.9% from FY2024.

  • Research & Development carries a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
  • Going back by year, Research & Development was $94.29 million in FY2024 (+23.8%), $76.19 million in FY2023 (-39.2%), $125.35 million in FY2022 (-43.7%) and $222.58 million in FY2021 (+34.2%).
  • The Q2 2026 figure represents the highest quarterly Research & Development in data going back to Q2 2011.
  • Year-over-year, Research & Development has increased for eight consecutive quarters, with growth averaging 72.0% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in Q2 2026 (growth of 200.0%), and the weakest in Q1 2023 (a decline of 67.0%).
  • Business Quant data shows TGTX's Research & Development at $48.4 million (Q1 2026), $41.19 million (Q4 2025) and $40.88 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 95.34 Mn
Mar 31, 2026 48.40 Mn
Dec 31, 2025 41.19 Mn
Sep 30, 2025 40.88 Mn
Jun 30, 2025 31.78 Mn
Mar 31, 2025 46.36 Mn
Dec 31, 2024 23.87 Mn
Sep 30, 2024 20.14 Mn
Jun 30, 2024 17.56 Mn
Mar 31, 2024 32.72 Mn
Dec 31, 2023 17.45 Mn
Sep 30, 2023 14.75 Mn
Jun 30, 2023 28.12 Mn
Mar 31, 2023 15.87 Mn
Dec 31, 2022 29.64 Mn
Sep 30, 2022 20.80 Mn
Jun 30, 2022 26.87 Mn
Mar 31, 2022 48.04 Mn
Dec 31, 2021 62.65 Mn
Sep 30, 2021 51.97 Mn
API Access

Tg Therapeutics, Inc. Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=TGTX&period=max&api_key=YOUR_API_KEY